NHS
Two-thirds of Britons with common life-threatening conditions have been denied care during pandemic
June 8, 2020Sales and Marketing COVID, COVID-19, NHS, NHS England, coronavirus, pandemic
Nearly two-thirds of people in Britain have been denied care for common life-threatening conditions by the NHS, due to their …
British COVID-19 test-and-trace system will not be fully operational until September, despite it launching last month
June 5, 2020Medical Communications COVID-19, NHS, coronavirus
The NHS COVID-19 test-and-trace system will not be fully operational until September or October, leaked emails from personnel involved with …
How Big Brother is helping to fight COVID-19
June 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, NHS, coronavirus, feeature, pharma, track and trace
Following the unprecedented disruption created by COVID-19, many governments are increasingly looking at using data from contact-tracing apps to help …
NICE gives thumbs-up to Roche’s Kadcyla in HER2+ breast cancer sub-population
May 7, 2020Sales and Marketing Cancer, Kadcyla, NHS, NICE, Roche, UK, breast cancer
NICE has revealed that it has recommended the NHS use of Roche’s Kadcyla (trastuzumab emtansine) for HER2+ breast cancer in …
12 British children hospitalised with rare condition linked to COVID-19
April 28, 2020Manufacturing and Production COVID-19, NHS, NHS UK, coronavirus
12 children have fallen ill across the UK with a new and potentially fatal combination of symptoms linked to COVID-19. …
Scottish Medicines Consortium approves new drugs in multiple sclerosis, ulcerative colitis and diabetes
April 15, 2020Research and Development, Sales and Marketing Biogen, Fambyra, Janssen, NHS, Rimzoic, Sandoz, Sanofi, Scotland, Scottish Medicines Consortium, Stelara, Suliqua, pharma
Medical regulation must still continue even in a global pandemic, and the Scottish Medicines Consortium, (SMC) has ploughed on with …
NICE promotes Professor Gillian Leng as its new Chief Executive
March 18, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, pharma
NICE, the drug watchdog for the NHS in England and Wales, has announced that it has promoted Professor Gillian Leng …
NHS England to supply HIV prevention drug PrEP with £16m government investment
March 16, 2020Manufacturing and Production, Sales and Marketing NHS, NHS England, PrEP HIV, PrEP< HIV, UK, pharma
NHS England is set to fund the availability of pre-exposure prophylaxis (PrEP) for the prevention of HIV for local authorities …
Keytruda rejected for NHS use for bladder cancer, will be removed from the Cancer Drugs Fund
March 12, 2020Sales and Marketing Cancer, Kidney cancer, MSD, NHS, NICE, blader cancer, keytruda, pharma
MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) has been knocked back by NICE for use on the NHS as a treatment for …
NICE shoots down Dupixent for severe asthma
March 9, 2020Sales and Marketing Dupixent, NHS, NICE, Regeneron, Sanofi, UK, asthma
NICE, the NHS’ drug watchdog in England and Wales, has announced its decision not to recommend Sanofi and Regeneron’s IL-4 …
NICE recommends avatrombopag to treat thrombocytopenia in chronic liver disease
March 4, 2020Research and Development Avatrombopag, NHS, NICE, UK, chronic liver disease
UK drug watchdog NICE has announced its final draft guidance recommending avatrombopag for routine use on the NHS in England …
NICE rejects Roche’s Polivy combo in relapsed or refractory diffuse large B-cell lymphoma
February 26, 2020Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, Polivy, Roche
It has been revealed that UK drug watchdog NICE has chosen to reject Roche’s Polivy (polatuzumab vedotin), used alongside rituximab …
NICE does not recommend cancer drug combination to the NHS
February 13, 2020Business Services Cancer, Kidney cancer, NHS, NICE, keytruda, kidney disease
NICE has published draft guidance that does not recommend a new drug combination to combat untreated advanced renal cell carcinoma …
New report finds that health inequality in the UK greater than previously thought
February 12, 2020Research and Development NHS, NICE, type 2 diabetes
Men are living seven years in poor health while women are living nearly ten years, according to a new report. …
Scotland approves targetted combination therapy for advanced melanoma
February 11, 2020Manufacturing and Production NHS, SMC, Scotland, UK, advanced melanoma, melanoma
The Scottish Medicines Consortium (SMC) has approved targeted combination therapy for the treatment of adult patient with unresectable or metastatic …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
